Related Experiment Video
Updated: May 31, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured
Masashi Miura1, Haru Kato, Osamu Matsushita
1Department of Foodborne Infection Research (SRL, Inc.), Kitasato University School of Medicine, 1-15-1 Sagamihara-shi, Minami-ku, Kanagawa 252-0374, Japan. miuram@med.kitasato-u.ac.jp
Abstract:
Two glucosylating toxins named toxins A and B play a role in the pathogenesis of Clostridium Difficile infection. The interaction of the toxins with host cell factors proceeds to downstream stages of cytotoxic effects in cells, in which involvement of other C. difficile factors remains unknown. We utilized culture filtrate of C. difficile with a low dilution to characterize the influence of putative minor proteins on the organization of the actin cytoskeleton in cultured epithelial cells and found a previously uncharacterized F-actin aggregated structure, termed "actin aggregate," at the juxtanuclear region. We reasoned that formation of actin aggregate was due to an additional factor(s) in the culture filtrate rather than the glucosylating toxins, because treatment of purified toxins rarely caused actin aggregate in cells. We focused on a previously uncharacterized hypothetical protein harboring a KDEL-like sequence as a candidate. The product of the candidate gene was detected in culture filtrate of C. difficile ATCC 9689 and was renamed Srl. Purified glutathione S-transferase-tagged Srl triggered formation of actin aggregate in the cells in the presence of either toxin A or B and enhanced cytotoxicity of each of the two toxins, including decreases in both cell viability and transepithelial resistance of cultured epithelial monolayer, although the recombinant Srl alone did not show detectable cytotoxicity. Srl-neutralized culture filtrate partially inhibited morphological changes of the cells in parallel with decreased actin aggregate formation in the cells. Thus, Srl might contribute to the modulation of toxin sensitivity of intestinal epithelial cells by enhancing cytotoxicity of C. difficile toxins.
Insights
A newly discovered protein, Srl, from Clostridium difficile enhances the harmful effects of toxins A and B. This protein contributes to disease severity by increasing toxin-induced cell damage in intestinal epithelial cells.
Area of Science:
- Microbiology
- Cell Biology
- Pathogenesis
Background:
- Clostridium difficile infection is a significant cause of antibiotic-associated diarrhea.
- Toxins A and B are key virulence factors, but other bacterial factors may contribute to disease.
- The precise mechanisms of C. difficile pathogenesis, particularly the role of minor proteins, are not fully understood.
Purpose of the Study:
- To investigate the role of minor proteins in C. difficile pathogenesis.
- To identify novel factors that influence host cell responses to C. difficile toxins.
- To characterize the function of a previously uncharacterized protein, Srl, in modulating toxin activity.
Main Methods:
- Analysis of C. difficile culture filtrate to identify factors affecting actin cytoskeleton organization.
- Characterization of a novel F-actin aggregated structure termed "actin aggregate."
- Purification and functional analysis of the hypothetical protein Srl, including its effect on cell viability and transepithelial resistance.
Main Results:
- A previously uncharacterized protein, Srl, was identified in C. difficile culture filtrate.
- Recombinant Srl induced actin aggregate formation and enhanced the cytotoxicity of toxins A and B.
- Srl alone did not exhibit cytotoxicity, but it potentiated toxin-induced decreases in cell viability and transepithelial resistance.
Conclusions:
- Srl is a novel C. difficile factor that enhances the cytotoxicity of toxins A and B.
- Srl may contribute to the pathogenesis of C. difficile infection by modulating intestinal epithelial cell sensitivity to toxins.
- Targeting Srl could be a potential therapeutic strategy to reduce C. difficile-associated disease severity.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Toxins
Regulation of Bacterial Virulence

